Sapheon seeks FDA approval for device to treat varicose veins

09/23/2013 | MassDevice.com (Boston)

Sapheon has filed with the FDA the first module of its premarket approval application for VenaSeal Sapheon, a device used for treating varicose veins. The system, which already has CE mark approval in Europe, is undergoing an investigational device exemption trial in the U.S.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI